Viewing Study NCT00132756


Ignite Creation Date: 2025-12-24 @ 11:24 PM
Ignite Modification Date: 2026-02-20 @ 1:45 PM
Study NCT ID: NCT00132756
Status: TERMINATED
Last Update Posted: 2006-11-08
First Post: 2005-08-18
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Liposomal Doxorubicin and Estramustine Phosphate: Study in Taxane Resistant, Hormone Refractory Advanced Prostate Cancer
Sponsor: Morton Plant Mease Health Care
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module